Medipal Holdings Corporation operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medipal Holdings with three other
companies in this sector in Japan:
Alfresa Holdings Corporation
sales of 2.60 trillion Japanese Yen [US$23.48 billion]
Toho Holdings Company Limited
(1.21 trillion Japanese Yen [US$10.94 billion]
Suzuken Co., Ltd.
(2.12 trillion Japanese Yen [US$19.16 billion]
Medipal Holdings reported sales of ¥3.15 trillion (US$28.38 billion)
March of 2018.
increase of 2.7%
versus 2017, when the company's sales were ¥3.06 trillion.
This was the third consecutive year of growth at Medipal Holdings.